Autonomix Medical Cash Flow Statement (2022-2025) | AMIX

Cash Flow Statement Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter) -0.54M-0.66M-0.86M-6.04M-3.11M-5.41M-2.70M-2.81M-2.71M-3.19M-3.34M-7.45M-3.26M
Share-based Compensation (Quarter) 0.00M0.00M0.10M0.03M0.10M0.39M3.30M0.10M
Gains from Investment Securities (Quarter) 0.24M0.20M3.00M
Cash from Operations (Quarter) -0.67M-0.70M-1.10M-2.56M-6.65M-1.90M-1.50M-2.30M-8.26M-2.60M-3.82M-2.97M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter) 0.04M0.08M0.04M0.04M0.05M0.18M0.00M0.00M0.00M
Change in Working Capital
Change in Account Payables (Quarter) -0.01M0.21M0.02M0.26M0.32M-0.20M0.29M-0.34M0.18M0.14M0.03M-0.16M
Change in Accured Expenses (Quarter) 0.05M0.02M-0.03M0.28M0.24M0.19M0.21M0.20M0.75M0.12M-0.50M0.29M
Investing Activities
Capital Expenditures (Quarter) 0.02M0.02M0.01M0.01M0.01M0.01M
Cash from Investing Activities (Quarter) -0.02M-0.02M-0.01M-0.01M-0.01M-0.01M
Financing Activities
Other financing activities (Quarter) 0.35M-0.35M1.05M4.50
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter) 0.35M1.65M2.00M
Change in Capital Stock
Shares Issued (Quarter) 0.16M0.10M0.32M0.22M0.24M0.24M0.25M0.01M0.01M
Net Equity Issued and Repurchased (Quarter) 0.68M2.84M0.00M2.12M-0.02M1.30M
Misc.
Cash from Financing Activities (Quarter) 0.68M2.73M0.35M1.65M14.41M8.97M8.80M2.06M2.71M5.43M
Change in Cash (Quarter) 0.06M2.07M-0.79M-0.93M7.74M-1.86M-1.60M6.67M0.53M-0.55M-1.11M2.46M
Free Cash Flow (Quarter) -0.67M-0.70M-1.10M-2.58M-6.67M-1.91M-1.50M-2.31M-8.27M-2.60M-3.82M-2.98M
Net Cash Flow (Quarter) 0.01M2.04M-0.75M-0.93M7.74M-1.91M-1.50M6.67M0.53M-0.55M-1.11M2.46M